Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015

Sr. No.	Particulars as per SEBI (LODR)	Weblink
1	Details of business	https://www.aartidrugs.co.in/company-profile
2	Terms and conditions of Appointment of Independent Directors	https://www.aartidrugs.co.in/wp-content/uploads/2020/06/Terms-and-Conditions-of-Appointment-of-Independent-Director.pdf
3	Composition of Committees of Board of Directors	https://www.aartidrugs.co.in/wp-content/uploads/2022/10/Composition-of-Committees_ADL.pdf
4	Code of Conduct	https://www.aartidrugs.co.in/wp-content/uploads/2021/05/Code-of-Conduct.pdf
5	Vigil mechanism/ Whistle Blower policy	https://www.aartidrugs.co.in/wp-content/uploads/2020/11/Whistle-Blower-Policy.pdf
6	Criteria for making payment to Non Executive Directors	http://www.aartidrugs.co.in/wp-content/uploads/2020/06/Nomination-and-Remuneration-Policy-1.pdf
7	Policy on Related Party Transactions	https://www.aartidrugs.co.in/wp-content/uploads/2022/05/Related-Party-Transaction-Policy.pdf
8	Policy for determining Material Subsidiaries	https://www.aartidrugs.co.in/wp-content/uploads/2022/05/Policy-For-determining-Material-Subsidiary.pdf
9	Familiarization programmes imparted to Independent Directors	https://www.aartidrugs.co.in/independent-directors
10	Contact details for Grievance Redressal	https://www.aartidrugs.co.in/stock-information
11	Financial Information	https://www.aartidrugs.co.in/quarterly-reports
12	Shareholding Pattern	https://www.aartidrugs.co.in/shareholding-pattern
13	Details of agreements entered into with the media companies and/or their associates	No such agreements were entered into with the media companies and/or their associates.
14	Details of analysts or institutional investors meet	https://www.aartidrugs.co.in/concall-recording
15	New Name and Old name of the Company	N.A.
16	Disclosures under Regulation 47(1) of LODR	https://www.aartidrugs.co.in/notice
17	Credit Rating	https://www.aartidrugs.co.in/credit-ratings
18	Subsidiary Financial Statements	https://www.aartidrugs.co.in/subsidiary-financials
19	Secretarial Compliance Report	https://www.aartidrugs.co.in/annual-secretarial-compliance-report-2
20	Materiality Policy	http://www.aartidrugs.co.in/wp-content/uploads/2019/09/materiality-policy.pdf
21	Contact details of KMP for determining materiality	http://www.aartidrugs.co.in/stock-information
22	Disclosures under Regulation 30(8) of SEBI (LODR) Regulations, 2015	https://www.aartidrugs.co.in/notice
23	Dividend Distribution Policy	http://www.aartidrugs.co.in/wp-content/uploads/2019/09/dividend-distribution-policy.pdf
24	Annual Return	https://www.aartidrugs.co.in/annual-return